These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Structure-activity relationship (SAR) and molecular dynamics study of withaferin-A fragment derivatives as potential therapeutic lead against main protease (M Ghosh A; Chakraborty M; Chandra A; Alam MP J Mol Model; 2021 Feb; 27(3):97. PubMed ID: 33641023 [TBL] [Abstract][Full Text] [Related]
5. An Updated Review on SARS-CoV-2 Main Proteinase (M Sabbah DA; Hajjo R; Bardaweel SK; Zhong HA Curr Top Med Chem; 2021; 21(6):442-460. PubMed ID: 33292134 [TBL] [Abstract][Full Text] [Related]
6. An automated positive selection screen in yeast provides support for boron-containing compounds as inhibitors of SARS-CoV-2 main protease. Sigurdardóttir S; Silva SF; Tiukova I; Alalam H; King RD; Grøtli M; Eriksson LA; Sunnerhagen P Microbiol Spectr; 2024 Oct; 12(10):e0124924. PubMed ID: 39162260 [TBL] [Abstract][Full Text] [Related]
7. Discovery of SARS-CoV-2 main protease covalent inhibitors from a DNA-encoded library selection. Ge R; Shen Z; Yin J; Chen W; Zhang Q; An Y; Tang D; Satz AL; Su W; Kuai L SLAS Discov; 2022 Mar; 27(2):79-85. PubMed ID: 35063690 [TBL] [Abstract][Full Text] [Related]
8. Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries. Akaberi D; Pourghasemi Lati M; Krambrich J; Berger J; Neilsen G; Strandback E; Turunen SP; Wannberg J; Gullberg H; Moche M; Chinthakindi PK; Nyman T; Sarafianos SG; Sandström A; Järhult JD; Sandberg K; Lundkvist Å; Verho O; Lennerstrand J Antimicrob Agents Chemother; 2024 Oct; 68(10):e0090924. PubMed ID: 39194208 [No Abstract] [Full Text] [Related]
9. In silico Study to Evaluate the Antiviral Activity of Novel Structures against 3C-like Protease of Novel Coronavirus (COVID-19) and SARS-CoV. Chunduru K; Sankhe R; Begum F; Sodum N; Kumar N; Kishore A; Shenoy RR; Rao CM; Saravu K Med Chem; 2021; 17(4):380-395. PubMed ID: 32720605 [TBL] [Abstract][Full Text] [Related]
10. Discovery of highly potent SARS-CoV-2 M Chen W; Feng B; Han S; Wang P; Chen W; Zang Y; Li J; Hu Y Bioorg Med Chem Lett; 2022 Feb; 58():128526. PubMed ID: 34998903 [TBL] [Abstract][Full Text] [Related]
11. Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors. Huff S; Kummetha IR; Tiwari SK; Huante MB; Clark AE; Wang S; Bray W; Smith D; Carlin AF; Endsley M; Rana TM J Med Chem; 2022 Feb; 65(4):2866-2879. PubMed ID: 34570513 [TBL] [Abstract][Full Text] [Related]
12. Computational Selectivity Assessment of Protease Inhibitors against SARS-CoV-2. Fischer A; Sellner M; Mitusińska K; Bzówka M; Lill MA; Góra A; Smieško M Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669738 [TBL] [Abstract][Full Text] [Related]
13. Re Karges J; Kalaj M; Gembicky M; Cohen SM Angew Chem Int Ed Engl; 2021 May; 60(19):10716-10723. PubMed ID: 33606889 [TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 M Rut W; Groborz K; Zhang L; Sun X; Zmudzinski M; Pawlik B; Wang X; Jochmans D; Neyts J; Młynarski W; Hilgenfeld R; Drag M Nat Chem Biol; 2021 Feb; 17(2):222-228. PubMed ID: 33093684 [TBL] [Abstract][Full Text] [Related]
15. Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors from Molecular Modeling Studies. Diniz LRL; Perez-Castillo Y; Elshabrawy HA; Filho CDSMB; de Sousa DP Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33430299 [TBL] [Abstract][Full Text] [Related]
18. Discovery of the potent covalent inhibitor with an acrylate warhead for SARS-CoV-2 3CL protease. Shen W; Chen X; Zhou L; Cheng Y; Zhang Y; Jiang X; Sun H; Shen J Bioorg Med Chem Lett; 2024 Nov; 112():129942. PubMed ID: 39218405 [TBL] [Abstract][Full Text] [Related]
19. Discovery of meisoindigo derivatives as noncovalent and orally available M Gao Q; Liu S; Zhou Y; Fan J; Ke S; Zhou Y; Fan K; Wang Y; Zhou Y; Xia Z; Deng X Eur J Med Chem; 2024 Jul; 273():116498. PubMed ID: 38762916 [TBL] [Abstract][Full Text] [Related]
20. Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188. Lockbaum GJ; Reyes AC; Lee JM; Tilvawala R; Nalivaika EA; Ali A; Kurt Yilmaz N; Thompson PR; Schiffer CA Viruses; 2021 Jan; 13(2):. PubMed ID: 33503819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]